167 related articles for article (PubMed ID: 36472871)
1. Melanoma Treatments and Mortality Rate Trends in the US, 1975 to 2019.
Kahlon N; Doddi S; Yousif R; Najib S; Sheikh T; Abuhelwa Z; Burmeister C; Hamouda DM
JAMA Netw Open; 2022 Dec; 5(12):e2245269. PubMed ID: 36472871
[TBL] [Abstract][Full Text] [Related]
2. New Systematic Therapies and Trends in Cutaneous Melanoma Deaths Among US Whites, 1986-2016.
Berk-Krauss J; Stein JA; Weber J; Polsky D; Geller AC
Am J Public Health; 2020 May; 110(5):731-733. PubMed ID: 32191523
[No Abstract] [Full Text] [Related]
3. Age-Specific Incidence of Melanoma in the United States.
Paulson KG; Gupta D; Kim TS; Veatch JR; Byrd DR; Bhatia S; Wojcik K; Chapuis AG; Thompson JA; Madeleine MM; Gardner JM
JAMA Dermatol; 2020 Jan; 156(1):57-64. PubMed ID: 31721989
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
5. Cancer Drug Approvals That Displaced Existing Standard-of-Care Therapies, 2016-2021.
Benjamin DJ; Xu A; Lythgoe MP; Prasad V
JAMA Netw Open; 2022 Mar; 5(3):e222265. PubMed ID: 35289858
[TBL] [Abstract][Full Text] [Related]
6. Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019.
Lythgoe MP; Desai A; Gyawali B; Savage P; Krell J; Warner JL; Khaki AR
JAMA Netw Open; 2022 Jun; 5(6):e2216183. PubMed ID: 35687337
[TBL] [Abstract][Full Text] [Related]
7. Trends in the Incidence of Early-Onset Colorectal Adenocarcinoma Among Black and White US Residents Aged 40 to 49 Years, 2000-2017.
Montminy EM; Zhou M; Maniscalco L; Penrose H; Yen T; Patel SG; Wu XC; Karlitz JJ
JAMA Netw Open; 2021 Nov; 4(11):e2130433. PubMed ID: 34751760
[TBL] [Abstract][Full Text] [Related]
8. Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016.
Acheampong T; Kehm RD; Terry MB; Argov EL; Tehranifar P
JAMA Netw Open; 2020 Aug; 3(8):e2013226. PubMed ID: 32804214
[TBL] [Abstract][Full Text] [Related]
9. Trends in Alcohol-Induced Deaths in the United States, 2000-2016.
Spillane S; Shiels MS; Best AF; Haozous EA; Withrow DR; Chen Y; Berrington de González A; Freedman ND
JAMA Netw Open; 2020 Feb; 3(2):e1921451. PubMed ID: 32083687
[TBL] [Abstract][Full Text] [Related]
10. Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021.
Gupta R; Morten CJ; Zhu AY; Ramachandran R; Shah ND; Ross JS
JAMA Health Forum; 2022 May; 3(5):e221096. PubMed ID: 35977259
[TBL] [Abstract][Full Text] [Related]
11. Survival trends among patients with metastatic melanoma in the pretargeted and the post-targeted era: a US population-based study.
Uprety D; Bista A; Chennamadhavuni A; Niroula A; Jafri SIM; Smith A; Arjyal L
Melanoma Res; 2018 Feb; 28(1):56-60. PubMed ID: 29023264
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019.
Dhodapkar M; Zhang AD; Puthumana J; Downing NS; Shah ND; Ross JS
JAMA Netw Open; 2021 Jun; 4(6):e2113224. PubMed ID: 34110392
[TBL] [Abstract][Full Text] [Related]
13. Time trends of incidence of age-associated diseases in the US elderly population: Medicare-based analysis.
Akushevich I; Kravchenko J; Ukraintseva S; Arbeev K; Yashin AI
Age Ageing; 2013 Jul; 42(4):494-500. PubMed ID: 23482353
[TBL] [Abstract][Full Text] [Related]
14. Trends in Mortality From Drug Poisonings, Suicide, and Alcohol-Induced Deaths in the United States From 2000 to 2017.
Shiels MS; Tatalovich Z; Chen Y; Haozous EA; Hartge P; Nápoles AM; Pérez-Stable EJ; Rodriquez EJ; Spillane S; Thomas DA; Withrow DR; Berrington de González A; Freedman ND
JAMA Netw Open; 2020 Sep; 3(9):e2016217. PubMed ID: 32915234
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Thyroid Cancer Incidence and Mortality Trends in the United States, 1973-2013.
Qian ZJ; Jin MC; Meister KD; Megwalu UC
JAMA Otolaryngol Head Neck Surg; 2019 Jul; 145(7):617-623. PubMed ID: 31120475
[TBL] [Abstract][Full Text] [Related]
16. Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016.
Ladanie A; Schmitt AM; Speich B; Naudet F; Agarwal A; Pereira TV; Sclafani F; Herbrand AK; Briel M; Martin-Liberal J; Schmid T; Ewald H; Ioannidis JPA; Bucher HC; Kasenda B; Hemkens LG
JAMA Netw Open; 2020 Nov; 3(11):e2024406. PubMed ID: 33170262
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017.
Zhang AD; Puthumana J; Downing NS; Shah ND; Krumholz HM; Ross JS
JAMA Netw Open; 2020 Apr; 3(4):e203284. PubMed ID: 32315070
[TBL] [Abstract][Full Text] [Related]
18. Trends in cause of death among patients with multiple myeloma in Puerto Rico and the United States SEER population, 1987-2013.
Castañeda-Avila MA; Ortiz-Ortiz KJ; Torres-Cintrón CR; Birmann BM; Epstein MM
Int J Cancer; 2020 Jan; 146(1):35-43. PubMed ID: 30802944
[TBL] [Abstract][Full Text] [Related]
19. Trends in Premature Deaths Among Adults in the United States and Latin America.
Chen Y; Freedman ND; Rodriquez EJ; Shiels MS; Napoles AM; Withrow DR; Spillane S; Sigel B; Perez-Stable EJ; Berrington de González A
JAMA Netw Open; 2020 Feb; 3(2):e1921085. PubMed ID: 32049297
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs.
Miller JE; Mello MM; Wallach JD; Gudbranson EM; Bohlig B; Ross JS; Gross CP; Bach PB
JAMA Netw Open; 2021 May; 4(5):e217075. PubMed ID: 33950209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
